Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Chartmill

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
99 100 Next >
EOG Resources Inc (NYSE:EOG) is a Compelling Value Pick with Strong Financial Health and Profitability. ↗
Via Chartmill
Tickers EOG
What's going on in today's pre-market session: S&P500 movers ↗
Via Chartmill
Tickers AMD APA COHR HOOD INTC J
Neurocrine Biosciences (NASDAQ:NBIX) Screens as a Peter Lynch-Style GARP Opportunity ↗
Via Chartmill
Tickers NBIX
Get insights into the top gainers and losers of Tuesday's pre-market session. ↗
Via Chartmill
Tickers AMBO BZFD CNCK CREG CVM GTM
Under Armour Inc-CLASS A (NYSE:UAA) Plunges After Q4 Earnings Miss and Weak Fiscal 2027 Guidance ↗
Via Chartmill
Topics Earnings
Tickers UAA
Vestis Corp (NYSE:VSTS) Q2 Earnings Beat, Upgrades Full-Year Guidance ↗
Via Chartmill
Topics Earnings
Tickers VSTS
Legend Biotech (NASDAQ:LEGN) Q1 2026 Revenue Surges on CARVYKTI Growth, but EPS Falls Short ↗
Via Chartmill
Tickers LEGN
D-Wave Quantum Inc. (NYSE:QBTS) Q1 Revenue Misses but Record Bookings Send Stock Higher ↗
Via Chartmill
Tickers QBTS
Veritone (VERI) Plunges After Q1 Revenue Miss but Reaffirms Full-Year Growth Targets ↗
Via Chartmill
Tickers VERI
Camtek (NASDAQ:CAMT) Q1 2026 Results Inline with Estimates, Shares Dip on Mixed Guidance ↗
Via Chartmill
Tickers CAMT
Tenax Therapeutics (NASDAQ:TENX) Q1 2026 Slightly Beats EPS, Gears Up for Pivotal Phase 3 Data in Q3 ↗
Via Chartmill
Tickers TENX
Janus International Group (NYSE:JBI) Q1 Results: Revenue Beat Overshadowed by EPS Miss ↗
Via Chartmill
Tickers JBI
Arvinas (NASDAQ:ARVN) Q1 2026 Results: First-Ever PROTAC Approval Offsets Revenue Miss ↗
Via Chartmill
Tickers ARVN
ACHV Stock Surges After Achieve Life Sciences Reports Market-Beating Q1 2026 Earnings ↗
Via Chartmill
Tickers ACHV
Harvard Bioscience Inc (NASDAQ:HBIO) Q1 Results Show Revenue Miss Offsets Earnings Beat ↗
Via Chartmill
Tickers HBIO
Olema Pharmaceuticals (NASDAQ:OLMA) Reports Narrower Q1 Loss, Eyes Fall Breast Cancer Data Readout ↗
Via Chartmill
Tickers OLMA
Prelude Therapeutics (NASDAQ:PRLD) Reports Narrower Quarterly Loss, Shares Rise on Cash Runway Extension ↗
Via Chartmill
Tickers PRLD
Acumen Pharmaceuticals (NASDAQ:ABOS) Q1 2026 Loss Narrows as Phase 2 Alzheimer's Trial Readout Looms ↗
Via Chartmill
Tickers ABOS
Broadwind Inc. (NASDAQ:BWEN) Surges After Q1 2026 Earnings Beat ↗
Via Chartmill
Tickers BWEN
ACURX PHARMACEUTICALS INC (NASDAQ:ACXP) Q1 Results Beat Estimates as Pipeline Advances Steadily ↗
Via Chartmill
Tickers ACXP
eToro Group Ltd. (NASDAQ:ETOR) Surges After Q1 Earnings Beat ↗
Via Chartmill
Tickers ETOR
Ralliant (NYSE:RAL) Soars on Q1 Earnings Beat, Raises Full-Year Guidance ↗
Via Chartmill
Topics Earnings
Tickers RAL
NeurAxis (NRXS) Q1 2026 Revenue and EPS Beat Drive Record Revenue and Strong Pre-Market Gains ↗
Via Chartmill
Tickers NRXS
Ambiq Micro (NYSE:AMBQ) Surges on Blowout Q1 Earnings Beat and Sky-High Guidance ↗
Via Chartmill
Topics Earnings
Tickers AMBQ
McEwen Inc (NYSE:MUX) Passes Key Little Book Growth Tests, But Financial Health Raises Concerns ↗
Via Chartmill
Tickers MUX
Via Transportation (NYSE:VIA) Soars on Q1 Earnings Beat and Profitability Milestone ↗
Via Chartmill
Topics Earnings
Tickers VIA
Autodesk Inc (NASDAQ:ADSK) Shows Strong Growth and Favorable Technical Setup ↗
Via Chartmill
Tickers ADSK
Orla Mining Ltd (NYSEARCA:ORLA): A CAN SLIM Screener Standout for Growth Investors ↗
Via Chartmill
Tickers ORLA
WDAY (WORKDAY INC-CLASS A) Fits Peter Lynch GARP Screen with Low PEG and Strong Profitability ↗
Via Chartmill
Tickers WDAY
HubSpot Inc (NYSE:HUBS): An Affordable Growth Stock Worth Watching ↗
Via Chartmill
Tickers HUBS
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.